Neuroblastoma is a form of cancer that typically affects children under the age of five. Infants diagnosed with the most aggressive forms of the disease often die, usually after suffering treatment regimens that can involve combinations of surgery, chemotherapy, radiation, and immunotherapy. Decades of research have established that a protein called "N-MYC" plays a major role in promoting the deadliest forms of neuroblastoma, and made it clear that drugs capable of interfering with N-MYC in neuroblastoma cells would dramatically improve outcomes for children suffering this disease.

Vanderbilt University
2301 Vanderbilt Place, PMB 407749
Nashbille, TN 37240
United States